Indian pharmaceutical exports to the US, its largest market, saw a dip in early fiscal months, alongside a slight decline in shipments to West Asia. Despite these challenges, overall exports surged by over 6%, driven by strong performance in regions like ASEAN and Latin America, and a remarkable 37% growth in vaccine exports. This indicates a resilient industry adapting to global shifts.